img

Global Immune Checkpoint Blockers Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immune Checkpoint Blockers Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Immune Checkpoint Blockers report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immune Checkpoint Blockers market is projected to reach US$ 54210 million in 2034, increasing from US$ 17760 million in 2022, with the CAGR of 17.0% during the period of 2024 to 2034. Demand from Lung Cancer and Colorectal Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immune Checkpoint Blockers industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Immune Checkpoint Blockers key manufacturers include Bristol Myers Squibb, Merck, AstraZeneca and Roche, etc. Bristol Myers Squibb, Merck, AstraZeneca are top 3 players and held % sales share in total in 2022.
Immune Checkpoint Blockers can be divided into Anti-PD-L1 Drug, Anti-PD-1 Drug and CTLA4,, etc. Anti-PD-L1 Drug is the mainstream product in the market, accounting for % sales share globally in 2022.
Immune Checkpoint Blockers is widely used in various fields, such as Lung Cancer, Colorectal Cancer, BreastCancer and Prostate Cancer, etc. Lung Cancer provides greatest supports to the Immune Checkpoint Blockers industry development. In 2022, global % sales of Immune Checkpoint Blockers went into Lung Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Immune Checkpoint Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol Myers Squibb
Merck
AstraZeneca
Roche
Segment by Type
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4

Segment by Application


Lung Cancer
Colorectal Cancer
BreastCancer
Prostate Cancer
Melanoma
Blood Cancers

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Immune Checkpoint Blockers market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Immune Checkpoint Blockers, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Immune Checkpoint Blockers industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Immune Checkpoint Blockers in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Immune Checkpoint Blockers introduction, etc. Immune Checkpoint Blockers Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Immune Checkpoint Blockers market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Immune Checkpoint Blockers Market Overview
1.1 Immune Checkpoint Blockers Product Overview
1.2 Immune Checkpoint Blockers Market Segment by Type
1.2.1 Anti-PD-L1 Drug
1.2.2 Anti-PD-1 Drug
1.2.3 CTLA4
1.3 Global Immune Checkpoint Blockers Market Size by Type
1.3.1 Global Immune Checkpoint Blockers Market Size Overview by Type (2018-2034)
1.3.2 Global Immune Checkpoint Blockers Historic Market Size Review by Type (2018-2024)
1.3.3 Global Immune Checkpoint Blockers Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immune Checkpoint Blockers Sales Breakdown by Type (2018-2024)
1.4.2 Europe Immune Checkpoint Blockers Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Immune Checkpoint Blockers Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Immune Checkpoint Blockers Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Immune Checkpoint Blockers Sales Breakdown by Type (2018-2024)
2 Global Immune Checkpoint Blockers Market Competition by Company
2.1 Global Top Players by Immune Checkpoint Blockers Sales (2018-2024)
2.2 Global Top Players by Immune Checkpoint Blockers Revenue (2018-2024)
2.3 Global Top Players by Immune Checkpoint Blockers Price (2018-2024)
2.4 Global Top Manufacturers Immune Checkpoint Blockers Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immune Checkpoint Blockers Market Competitive Situation and Trends
2.5.1 Immune Checkpoint Blockers Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Immune Checkpoint Blockers Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Checkpoint Blockers as of 2022)
2.7 Date of Key Manufacturers Enter into Immune Checkpoint Blockers Market
2.8 Key Manufacturers Immune Checkpoint Blockers Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immune Checkpoint Blockers Status and Outlook by Region
3.1 Global Immune Checkpoint Blockers Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Immune Checkpoint Blockers Historic Market Size by Region
3.2.1 Global Immune Checkpoint Blockers Sales in Volume by Region (2018-2024)
3.2.2 Global Immune Checkpoint Blockers Sales in Value by Region (2018-2024)
3.2.3 Global Immune Checkpoint Blockers Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Immune Checkpoint Blockers Forecasted Market Size by Region
3.3.1 Global Immune Checkpoint Blockers Sales in Volume by Region (2024-2034)
3.3.2 Global Immune Checkpoint Blockers Sales in Value by Region (2024-2034)
3.3.3 Global Immune Checkpoint Blockers Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Immune Checkpoint Blockers by Application
4.1 Immune Checkpoint Blockers Market Segment by Application
4.1.1 Lung Cancer
4.1.2 Colorectal Cancer
4.1.3 BreastCancer
4.1.4 Prostate Cancer
4.1.5 Melanoma
4.1.6 Blood Cancers
4.2 Global Immune Checkpoint Blockers Market Size by Application
4.2.1 Global Immune Checkpoint Blockers Market Size Overview by Application (2018-2034)
4.2.2 Global Immune Checkpoint Blockers Historic Market Size Review by Application (2018-2024)
4.2.3 Global Immune Checkpoint Blockers Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immune Checkpoint Blockers Sales Breakdown by Application (2018-2024)
4.3.2 Europe Immune Checkpoint Blockers Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Immune Checkpoint Blockers Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Immune Checkpoint Blockers Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Immune Checkpoint Blockers Sales Breakdown by Application (2018-2024)
5 North America Immune Checkpoint Blockers by Country
5.1 North America Immune Checkpoint Blockers Historic Market Size by Country
5.1.1 North America Immune Checkpoint Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Immune Checkpoint Blockers Sales in Volume by Country (2018-2024)
5.1.3 North America Immune Checkpoint Blockers Sales in Value by Country (2018-2024)
5.2 North America Immune Checkpoint Blockers Forecasted Market Size by Country
5.2.1 North America Immune Checkpoint Blockers Sales in Volume by Country (2024-2034)
5.2.2 North America Immune Checkpoint Blockers Sales in Value by Country (2024-2034)
6 Europe Immune Checkpoint Blockers by Country
6.1 Europe Immune Checkpoint Blockers Historic Market Size by Country
6.1.1 Europe Immune Checkpoint Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Immune Checkpoint Blockers Sales in Volume by Country (2018-2024)
6.1.3 Europe Immune Checkpoint Blockers Sales in Value by Country (2018-2024)
6.2 Europe Immune Checkpoint Blockers Forecasted Market Size by Country
6.2.1 Europe Immune Checkpoint Blockers Sales in Volume by Country (2024-2034)
6.2.2 Europe Immune Checkpoint Blockers Sales in Value by Country (2024-2034)
7 Asia-Pacific Immune Checkpoint Blockers by Region
7.1 Asia-Pacific Immune Checkpoint Blockers Historic Market Size by Region
7.1.1 Asia-Pacific Immune Checkpoint Blockers Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Immune Checkpoint Blockers Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Immune Checkpoint Blockers Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Immune Checkpoint Blockers Forecasted Market Size by Region
7.2.1 Asia-Pacific Immune Checkpoint Blockers Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Immune Checkpoint Blockers Sales in Value by Region (2024-2034)
8 Latin America Immune Checkpoint Blockers by Country
8.1 Latin America Immune Checkpoint Blockers Historic Market Size by Country
8.1.1 Latin America Immune Checkpoint Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Immune Checkpoint Blockers Sales in Volume by Country (2018-2024)
8.1.3 Latin America Immune Checkpoint Blockers Sales in Value by Country (2018-2024)
8.2 Latin America Immune Checkpoint Blockers Forecasted Market Size by Country
8.2.1 Latin America Immune Checkpoint Blockers Sales in Volume by Country (2024-2034)
8.2.2 Latin America Immune Checkpoint Blockers Sales in Value by Country (2024-2034)
9 Middle East and Africa Immune Checkpoint Blockers by Country
9.1 Middle East and Africa Immune Checkpoint Blockers Historic Market Size by Country
9.1.1 Middle East and Africa Immune Checkpoint Blockers Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Immune Checkpoint Blockers Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Immune Checkpoint Blockers Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Immune Checkpoint Blockers Forecasted Market Size by Country
9.2.1 Middle East and Africa Immune Checkpoint Blockers Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Immune Checkpoint Blockers Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information
10.1.2 Bristol Myers Squibb Introduction and Business Overview
10.1.3 Bristol Myers Squibb Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bristol Myers Squibb Immune Checkpoint Blockers Products Offered
10.1.5 Bristol Myers Squibb Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Immune Checkpoint Blockers Products Offered
10.2.5 Merck Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AstraZeneca Immune Checkpoint Blockers Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Immune Checkpoint Blockers Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Roche Immune Checkpoint Blockers Products Offered
10.4.5 Roche Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immune Checkpoint Blockers Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immune Checkpoint Blockers Industrial Chain Analysis
11.4 Immune Checkpoint Blockers Market Dynamics
11.4.1 Immune Checkpoint Blockers Industry Trends
11.4.2 Immune Checkpoint Blockers Market Drivers
11.4.3 Immune Checkpoint Blockers Market Challenges
11.4.4 Immune Checkpoint Blockers Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immune Checkpoint Blockers Distributors
12.3 Immune Checkpoint Blockers Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Anti-PD-L1 Drug
Table 2. Major Company of Anti-PD-1 Drug
Table 3. Major Company of CTLA4
Table 4. Global Immune Checkpoint Blockers Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Immune Checkpoint Blockers Sales by Type (2018-2024) & (K Units)
Table 6. Global Immune Checkpoint Blockers Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Immune Checkpoint Blockers Sales by Type (2018-2024) & (US& Million)
Table 8. Global Immune Checkpoint Blockers Market Share in Value by Type (2018-2024)
Table 9. Global Immune Checkpoint Blockers Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Immune Checkpoint Blockers Sales by Type (2024-2034) & (K Units)
Table 11. Global Immune Checkpoint Blockers Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Immune Checkpoint Blockers Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Immune Checkpoint Blockers Sales Market Share in Value by Type (2024-2034)
Table 14. Global Immune Checkpoint Blockers Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Immune Checkpoint Blockers Sales by Type (2018-2024) & (K Units)
Table 16. North America Immune Checkpoint Blockers Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Immune Checkpoint Blockers Sales (K Units) by Type (2018-2024)
Table 18. Europe Immune Checkpoint Blockers Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Immune Checkpoint Blockers Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Immune Checkpoint Blockers Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Immune Checkpoint Blockers Sales (K Units) by Type (2018-2024)
Table 22. Latin America Immune Checkpoint Blockers Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Immune Checkpoint Blockers Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Immune Checkpoint Blockers Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Immune Checkpoint Blockers Sales by Company (2018-2024) & (K Units)
Table 26. Global Immune Checkpoint Blockers Sales Share by Company (2018-2024)
Table 27. Global Immune Checkpoint Blockers Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Immune Checkpoint Blockers Revenue Share by Company (2018-2024)
Table 29. Global Market Immune Checkpoint Blockers Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Immune Checkpoint Blockers Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Immune Checkpoint Blockers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immune Checkpoint Blockers as of 2022)
Table 33. Date of Key Manufacturers Enter into Immune Checkpoint Blockers Market
Table 34. Key Manufacturers Immune Checkpoint Blockers Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Immune Checkpoint Blockers Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Immune Checkpoint Blockers Sales by Region (2018-2024) & (K Units)
Table 38. Global Immune Checkpoint Blockers Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Immune Checkpoint Blockers Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Immune Checkpoint Blockers Sales Market Share in Value by Region (2018-2024)
Table 41. Global Immune Checkpoint Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Immune Checkpoint Blockers Sales by Region (2024-2034) & (K Units)
Table 43. Global Immune Checkpoint Blockers Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Immune Checkpoint Blockers Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Immune Checkpoint Blockers Sales Market Share in Value by Region (2024-2034)
Table 46. Global Immune Checkpoint Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Immune Checkpoint Blockers Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Immune Checkpoint Blockers Sales by Application (2018-2024) & (K Units)
Table 49. Global Immune Checkpoint Blockers Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Immune Checkpoint Blockers Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Immune Checkpoint Blockers Sales Market Share in Value by Application (2018-2024)
Table 52. Global Immune Checkpoint Blockers Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Immune Checkpoint Blockers Sales by Application (2024-2034) & (K Units)
Table 54. Global Immune Checkpoint Blockers Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Immune Checkpoint Blockers Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Immune Checkpoint Blockers Sales Market Share in Value by Application (2024-2034)
Table 57. Global Immune Checkpoint Blockers Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Immune Checkpoint Blockers Sales by Application (2018-2024) (K Units)
Table 59. North America Immune Checkpoint Blockers Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Immune Checkpoint Blockers Sales by Application (2018-2024) (K Units)
Table 61. Europe Immune Checkpoint Blockers Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Immune Checkpoint Blockers Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Immune Checkpoint Blockers Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Immune Checkpoint Blockers Sales by Application (2018-2024) (K Units)
Table 65. Latin America Immune Checkpoint Blockers Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Immune Checkpoint Blockers Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Immune Checkpoint Blockers Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Immune Checkpoint Blockers Sales by Country (2018-2024) & (K Units)
Table 69. North America Immune Checkpoint Blockers Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Immune Checkpoint Blockers Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Immune Checkpoint Blockers Sales Market Share in Value by Country (2018-2024)
Table 72. North America Immune Checkpoint Blockers Sales by Country (2024-2034) & (K Units)
Table 73. North America Immune Checkpoint Blockers Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Immune Checkpoint Blockers Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Immune Checkpoint Blockers Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Immune Checkpoint Blockers Sales by Country (2018-2024) & (K Units)
Table 77. Europe Immune Checkpoint Blockers Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Immune Checkpoint Blockers Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Immune Checkpoint Blockers Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Immune Checkpoint Blockers Sales by Country (2024-2034) & (K Units)
Table 81. Europe Immune Checkpoint Blockers Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Immune Checkpoint Blockers Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Immune Checkpoint Blockers Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Immune Checkpoint Blockers Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Immune Checkpoint Blockers Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Immune Checkpoint Blockers Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Immune Checkpoint Blockers Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Immune Checkpoint Blockers Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Immune Checkpoint Blockers Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Immune Checkpoint Blockers Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Immune Checkpoint Blockers Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Immune Checkpoint Blockers Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Immune Checkpoint Blockers Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Immune Checkpoint Blockers Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Immune Checkpoint Blockers Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Immune Checkpoint Blockers Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Immune Checkpoint Blockers Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Immune Checkpoint Blockers Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Immune Checkpoint Blockers Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Value by Country (2024-2034)
Table 108. Bristol Myers Squibb Company Information
Table 109. Bristol Myers Squibb Introduction and Business Overview
Table 110. Bristol Myers Squibb Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Bristol Myers Squibb Immune Checkpoint Blockers Product
Table 112. Bristol Myers Squibb Recent Development
Table 113. Merck Company Information
Table 114. Merck Introduction and Business Overview
Table 115. Merck Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Merck Immune Checkpoint Blockers Product
Table 117. Merck Recent Development
Table 118. AstraZeneca Company Information
Table 119. AstraZeneca Introduction and Business Overview
Table 120. AstraZeneca Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. AstraZeneca Immune Checkpoint Blockers Product
Table 122. AstraZeneca Recent Development
Table 123. Roche Company Information
Table 124. Roche Introduction and Business Overview
Table 125. Roche Immune Checkpoint Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Roche Immune Checkpoint Blockers Product
Table 127. Roche Recent Development
Table 128. Key Raw Materials Lists
Table 129. Raw Materials Key Suppliers Lists
Table 130. Immune Checkpoint Blockers Market Trends
Table 131. Immune Checkpoint Blockers Market Drivers
Table 132. Immune Checkpoint Blockers Market Challenges
Table 133. Immune Checkpoint Blockers Market Restraints
Table 134. Immune Checkpoint Blockers Distributors List
Table 135. Immune Checkpoint Blockers Downstream Customers
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Checkpoint Blockers Product Picture
Figure 2. Global Immune Checkpoint Blockers Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Immune Checkpoint Blockers Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Immune Checkpoint Blockers Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Anti-PD-L1 Drug
Figure 6. Global Anti-PD-L1 Drug Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Anti-PD-1 Drug
Figure 8. Global Anti-PD-1 Drug Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of CTLA4
Figure 10. Global CTLA4 Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Immune Checkpoint Blockers Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Immune Checkpoint Blockers Sales Market Share by Type in 2022 & 2034
Figure 13. North America Immune Checkpoint Blockers Sales Market Share in Volume by Type in 2022
Figure 14. North America Immune Checkpoint Blockers Sales Market Share in Value by Type in 2022
Figure 15. Europe Immune Checkpoint Blockers Sales Market Share in Volume by Type in 2022
Figure 16. Europe Immune Checkpoint Blockers Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Value by Type in 2022
Figure 19. Latin America Immune Checkpoint Blockers Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Immune Checkpoint Blockers Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Checkpoint Blockers Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Checkpoint Blockers Revenue in 2022
Figure 25. Immune Checkpoint Blockers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Lung Cancer
Figure 27. Global Lung Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Colorectal Cancer
Figure 29. Global Colorectal Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of BreastCancer
Figure 31. Global BreastCancer Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Prostate Cancer
Figure 33. Global Prostate Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Melanoma
Figure 35. Global Melanoma Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Blood Cancers
Figure 37. Global Blood Cancers Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Global Immune Checkpoint Blockers Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Immune Checkpoint Blockers Sales Market Share by Application in 2022 & 2034
Figure 40. North America Immune Checkpoint Blockers Sales Market Share in Volume by Application in 2022
Figure 41. North America Immune Checkpoint Blockers Sales Market Share in Value by Application in 2022
Figure 42. Europe Immune Checkpoint Blockers Sales Market Share in Volume by Application in 2022
Figure 43. Europe Immune Checkpoint Blockers Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Immune Checkpoint Blockers Sales Market Share in Value by Application in 2022
Figure 46. Latin America Immune Checkpoint Blockers Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Immune Checkpoint Blockers Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Immune Checkpoint Blockers Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Immune Checkpoint Blockers Manufacturing Cost Structure
Figure 51. Immune Checkpoint Blockers Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed